Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.35B | 40.62B | 53.05B | 57.55B | 46.59B | 37.63B |
Gross Profit | 5.95B | 5.74B | 2.12B | 4.44B | 3.44B | 5.17B |
EBITDA | 6.30B | 7.70B | 6.29B | 5.42B | 1.04B | 4.19B |
Net Income | 28.00M | 15.00M | 482.00M | 355.00M | 2.15B | 580.00M |
Balance Sheet | ||||||
Total Assets | 75.89B | 75.47B | 82.39B | 89.50B | 64.22B | 54.75B |
Cash, Cash Equivalents and Short-Term Investments | 4.27B | 4.03B | 3.84B | 2.87B | 2.59B | 2.74B |
Total Debt | 45.60B | 39.79B | 45.52B | 50.78B | 29.08B | 23.78B |
Total Liabilities | 61.03B | 58.17B | 63.85B | 71.03B | 51.22B | 43.41B |
Stockholders Equity | 2.16B | 1.75B | 1.90B | 64.92B | 60.82B | 52.28B |
Cash Flow | ||||||
Free Cash Flow | 1.35B | 761.00M | -158.00M | -737.00M | 243.00M | 2.80B |
Operating Cash Flow | 3.75B | 3.28B | 2.13B | 1.01B | 1.69B | 4.21B |
Investing Cash Flow | -3.20B | -2.33B | 2.54B | -18.72B | -8.93B | -2.33B |
Financing Cash Flow | 51.00M | -505.00M | -4.37B | 18.07B | 7.06B | -1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | C$1.80B | 23.60 | 21.65% | 1.38% | 11.48% | 38.41% | |
78 Outperform | C$5.63B | 47.86 | 9.64% | ― | 57.21% | 136.79% | |
73 Outperform | C$1.36B | 13.75 | 25.25% | 3.14% | 8.49% | 14.10% | |
71 Outperform | C$3.76B | 27.23 | 9.71% | 3.73% | 6.87% | 8.42% | |
63 Neutral | $3.11B | 2.83 | -0.29% | 1.00% | -36.55% | -102.52% | |
61 Neutral | C$7.16B | 0.03 | -4.20% | 2.33% | 9.17% | -34.08% | |
55 Neutral | C$3.57B | 19.38 | 21.26% | 2.46% | 3.90% | -57.75% |